Dr. Carson graduated from the Tulane University School of Medicine in 1990. He works in Morristown, TN and specializes in Ophthalmology. Dr. Carson is affiliated with Jefferson Memorial Hospital and Morristown-Hamblen Healthcare System.
Dr. Carson graduated from the University of Texas Medical School at Houston in 2002. He works in Sacramento, CA and specializes in Vascular Surgery. Dr. Carson is affiliated with UC Davis Medical Center.
Dr. Carson graduated from the University of Cincinnati College of Medicine in 1978. He works in Cincinnati, OH and specializes in Internal Medicine. Dr. Carson is affiliated with Bethesda North Hospital, Mercy Hospital Anderson and The Jewish Hospital.
University Of Colorado Hospital Nephrology 1635 Aurora Ct, Aurora, CO 80045 (720)8480749 (phone), (720)8480756 (fax)
Education:
Medical School Thomas Jefferson University, Jefferson Medical College Graduated: 2008
Conditions:
Acute Renal Failure Chronic Renal Disease
Languages:
English
Description:
Dr. Carson graduated from the Thomas Jefferson University, Jefferson Medical College in 2008. He works in Aurora, CO and specializes in Nephrology and Internal Medicine. Dr. Carson is affiliated with University Of Colorado Hospital.
Dr. Carson II graduated from the Pikeville College School of Osteopathic Medicine in 2002. He works in Gastonia, NC and specializes in Critical Care Medicine.
Dr. Carson graduated from the Loma Linda University School of Medicine in 1980. He works in Yuma, AZ and specializes in Emergency Medicine and Urgent Care Medicine. Dr. Carson is affiliated with Yuma Regional Medical Center.
Custom Manufacturing Corporation Bensalem, PA 2010 to 2014 Mechanical Engineer/Second Shift SupervisorChemson Inc Philadelphia, PA 2007 to 2010 Shipping & Logistics ManagerT & F Trucking Inc Mishawaka, IN 2005 to 2007 Warehouse SupervisorWel-Fab Morgantown, WV 1999 to 2004 Warehouse Associate
Education:
Notre Dame University South Bend, IN 2004 to 2006 M.S. in CommunicationsWest Virginia University Morgantown, WV 1999 to 2004 B.A. in Mechanical EngineeringRancocas Valley Regional High School Mount Holly, NJ 1994 to 1998 Diploma in General Studies
Skills:
**I do have extensive AutoCAD experience specifically SolidWorks BUT I have not used it in any capacity in a number of years**
Us Patents
Aroyl Aminoacyl Pyrroles For Use In The Treatment Of Neuropathic Pain
John R. Carson - Norristown PA Richard J. Carmosin - late of Quakertown PA Louis J. Fitzpatrick - Souderton PA Allen B. Reitz - Lansdale PA Michele C. Jetter - Norristown PA
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 314468
US Classification:
514326, 514329, 546224, 546208
Abstract:
4-[aryl(piperidin-4-yl)]aminobenzamides are delta-opioid receptor agonists/antagonists. As delta-opioid receptor agonists, such compounds are useful as analgesics. Depending on their agonist/antagonist effect, such compounds may also be useful immunosuppressants, antiinflammatory agents, agents for the treatment of mental illness, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents, and agents for the treatment of respiratory diseases.
Isoindolyl And Isoquinolinyl Aroyl Pyrrole Compounds
John R. Carson - Norristown PA Philip M. Pitis - North Wales PA
Assignee:
Ortho-McNeil Pharamaceutical, Inc. - Raritan NJ
International Classification:
C07D 40102
US Classification:
514307, 514416, 546146, 548465
Abstract:
This invention is directed to isoindolyl and isoquinolinyl aroyl pyrrole compounds pharmaceutically useful as agents or modulators for the treatment of central nervous system disorders and methods for the treatment of central nervous system disorders.
This invention is directed to aroyl aminoacyl pyrroles pharmaceutically useful as agents and modulators for the treatment of central nervous system disorders and a method for the treatment of central nervous system disorders including, but not limited to, use of the compounds of the present invention as anticonvulsant agents and modulators, antiepileptic agents and modulators, neuroprotective agents and modulators, muscle relaxant agents and modulators and as agents and modulators for the treatment of neuropathic pain.
Useful Aroyl Pyrrole Heteroaryl Methanones And Methanols
This invention is directed to aroyl pyrrole heteroaryl methanone and methanol compounds pharmaceutically useful as agents for treating or modulating a central nervous system disorder and methods for treating or modulating a central nervous system disorder.
Heteroaryl Alkylamide Derivatives Useful As Bradykinin Receptor Modulators
John R. Carson - Norristown PA, US Michele C. Jetter - Norristown PA, US Jung S. Lee - Ambler PA, US Mark A. Youngman - Warminster PA, US
Assignee:
Ortho-McNeil Pharmaceuticals, Inc. - Raritan NJ
International Classification:
A61K031/47 C07D215/12 C07D215/16
US Classification:
514314, 546174, 546175, 546177
Abstract:
This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.
John R. Carson - Norristown PA, US Philip M. Pitis - North Wales PA, US
Assignee:
Janssen Pharmaceutical N.V. - Beerse
International Classification:
C07C 233/65 A61K 31/165
US Classification:
564164, 514620
Abstract:
This invention is directed to carboxamido opioid compounds pharmaceutically useful as agents for treating or modulating a central nervous system disorder and methods for treating or modulating a central nervous system disorder.
Heteroaryl Alkylamide Derivatives Useful As Bradykinin Receptor Modulators
John R. Carson - Norristown PA, US Michele C. Jetter - Norristown PA, US Jung S. Lee - Ambler PA, US Mark A. Youngman - Warminster PA, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 31/47 C07D 215/38
US Classification:
514311, 514312, 514314, 546153, 546176, 546178
Abstract:
This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.